Tetrapyrrolic Glycosylated Macrocycles for an Application in PDT

Area of Science:

• Medicinal Chemistry
• Photodynamic Therapy
• Organic Synthesis

Background:

• Development of novel photosensitizers for cancer therapy is crucial.
• Porphyrins and their analogs are widely investigated for photodynamic therapy (PDT).
• Glycoconjugation can enhance water solubility and tumor targeting of photosensitizers.

Purpose of the Study:

• To synthesize and characterize novel amphiphilic glycoconjugated porphyrins, benzochlorins, and azaporphyrins.
• To evaluate the photocytotoxicity of these compounds against human tumoral cell lines.
• To investigate the structure-activity relationship of these glycoconjugates as photosensitizers.

Main Methods:

• Chemical synthesis of porphyrin, benzochlorin, and azaporphyrin derivatives.
• Amphiphilic modification and glycoconjugation strategies.
• In vitro photocytotoxicity assays using the human tumoral cell line HT29.
• Spectroscopic characterization (UV-Vis absorption).

Main Results:

• Successful synthesis and characterization of various amphiphilic glycoconjugated porphyrins, benzochlorins, and azaporphyrins.
• Several synthesized compounds demonstrated efficient photosensitizing capabilities in vitro.
• Glycosylated benzochlorins and azaporphyrins exhibited enhanced absorption in the red spectrum (>590 nm).
• These specific glycosylated compounds showed significant photocytotoxicity against HT29 tumor cells upon irradiation.

Conclusions:

• Amphiphilic glycoconjugated porphyrins, benzochlorins, and azaporphyrins are promising candidates for photodynamic cancer therapy.
• Glycosylation and the core structure (benzochlorin, azaporphyrin) significantly influence photosensitizing efficacy and spectral properties.
• Targeted irradiation with longer wavelengths (>590 nm) is effective for these novel photosensitizers.